AquaBounty Technologies, Inc.: management transactions · United States · SEC (Form 4)

About AquaBounty Technologies, Inc.

AquaBounty Technologies, Inc. (ticker: AQB) is a U.S.-listed company traded on the NASDAQ Stock Market in the United States. The company is best known for its long-standing focus on aquaculture innovation, particularly land-based salmon farming and related biotechnology. AquaBounty was incorporated in December 1991 in Delaware, originally to pursue research and development on antifreeze proteins, and later evolved into one of the most visible names in genetically enhanced seafood and controlled-environment aquaculture. Its operating headquarters is in Harvard, Massachusetts. From an industry perspective, AquaBounty has occupied a niche but highly distinctive position. Its business model historically combined technology development, regulatory execution, and fish production, with a strategic emphasis on improving farming efficiency and reducing some of the limitations associated with conventional ocean-based salmon farming. The company’s core story has been less about scale and more about scientific differentiation, intellectual property, and the attempt to commercialize a novel aquaculture platform. That said, the company’s current profile has changed materially in recent periods. Recent corporate actions indicate a significant restructuring phase. AquaBounty sold its Indiana grow-out farm in July 2024. In March 2025, it sold its Canadian subsidiary, including broodstock farms in Prince Edward Island, as well as its intellectual property tied to genetically engineered Atlantic salmon, along with related trademarks and patents. These divestitures substantially reduced the company’s direct production footprint and suggest a transition away from its earlier asset-heavy operating model. As a result, the equity story now looks more like a turnaround and capital management case than a conventional growth story. The company’s competitive position should therefore be viewed as specialized and high-risk. AquaBounty remains associated with the pioneering wave of land-based aquaculture, but it competes in an industry where economics, regulation, and scaling challenges are extremely demanding. For investors, especially in France, Belgium, and Switzerland, the key question is not whether the company has a recognizable innovation narrative, but whether it can convert that narrative into a sustainable commercial structure after asset sales and strategic resets. In recent filings, AquaBounty also showed ongoing financing activity. In February 2026, it completed a registered direct offering, and in April 2026 it disclosed an exchange of approximately $4.0 million of senior note principal plus accrued interest for Series A convertible preferred stock, convertible into common shares. This points to a balance sheet that still requires active management and reinforces the speculative nature of the name. Overall, AquaBounty is a small-cap NASDAQ company in the United States at the intersection of agriculture, food production, biotechnology, and sustainability. Its relevance comes from its pioneering history, its prior IP portfolio, and the market’s assessment of whether management can rebuild value after major divestitures and financing transactions.